Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019;15(10):2269-2285.
doi: 10.1080/21645515.2019.1649532. Epub 2019 Sep 5.

Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens

Anahita Fathi  1   2   3 , Christine Dahlke  1   2   3 , Marylyn M Addo  1   2   3
Affiliations
Review

Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens

Anahita Fathi et al. Hum Vaccin Immunother. 2019.

Abstract

The devastating Ebola virus (EBOV) outbreak in West Africa in 2013-2016 has flagged the need for the timely development of vaccines for high-threat pathogens. To be better prepared for new epidemics, the WHO has compiled a list of priority pathogens that are likely to cause future outbreaks and for which R&D efforts are, therefore, paramount (R&D Blueprint: https://www.who.int/blueprint/priority-diseases/en/ ). To this end, the detailed characterization of vaccine platforms is needed. The vesicular stomatitis virus (VSV) has been established as a robust vaccine vector backbone for infectious diseases for well over a decade. The recent clinical trials testing the vaccine candidate VSV-EBOV against EBOV disease now have added a substantial amount of clinical data and suggest VSV to be an ideal vaccine vector candidate for outbreak pathogens. In this review, we discuss insights gained from the clinical VSV-EBOV vaccine trials as well as from animal studies investigating vaccine candidates for Blueprint pathogens.

Keywords: Ebola virus; Lassa virus; Marburg virus; Nipah virus; V920; VSV-EBOV; emerging infections; rVSV; vector vaccine; vesicular stomatitis virus.

PubMed Disclaimer

References

    1. WHO Ten threats to global health in 2019 [Internet]. [accessed 2019 April3] https://www.who.int/emergencies/ten-threats-to-global-health-in-2019
    1. Oh M, Park WB, Park S-W, Choe PG, Bang JH, Song K-H, Kim ES, Bin KH, Kim NJ.. Middle East respiratory syndrome: what we learned from the 2015 outbreak in the Republic of Korea. Korean J Intern Med. 2018;33:233–46. doi: 10.3904/kjim.2018.031. - DOI - PMC - PubMed
    1. WHO WHO Director-General summarizes the outcome of the emergency committee regarding clusters of microcephaly and Guillain-Barré syndrome [Internet]. [accessed 2019 April3] https://www.who.int/en/news-room/detail/01-02-2016-who-director-general-...
    1. WHO WHO publishes list of top emerging diseases likely to cause major epidemics [Internet]. 2015. [accessed 2019 March24] https://www.who.int/medicines/ebola-treatment/WHO-list-of-top-emerging-d...
    1. WHO Methodology for prioritizing severe emerging diseases for research and development background [Internet]. 2017. [accessed 2019 June27] http://www.who.int/csr/research-and-development/meeting-report-prioritiz...

MeSH terms